E Fund Management Co., Ltd. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$435
+23.9%
21,160
+183.8%
0.03%
+17.9%
Q2 2023$351
-11.1%
7,457
-20.8%
0.03%
-3.4%
Q1 2023$395
+20.4%
9,412
+9.6%
0.03%
+7.4%
Q4 2022$328
-99.9%
8,588
-24.3%
0.03%
-34.1%
Q3 2022$444,000
+26.1%
11,341
+4.1%
0.04%
+28.1%
Q2 2022$352,000
+23.1%
10,895
+26.2%
0.03%
+255.6%
Q1 2022$286,0008,6340.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders